Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Quarterly results

TETRAPHASE PHARMACEUTICALS INC (TTPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2020 GN La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.
06/24/2020 GN La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
05/05/2020 GN SHAREHOLDER ALERT: WeissLaw LLP Reminds ETFC, TCO, TERP, and TTPH Shareholders About Its Ongoing Investigations
04/28/2020 GN SHAREHOLDER ALERT: WeissLaw LLP Reminds TTPH, TERP, LM, and ETFC Shareholders About Its Ongoing Investigations
04/27/2020 GN TTPH, FSB, FG, and OPB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
04/21/2020 GN SHAREHOLDER ALERT: WeissLaw LLP Reminds LM, TERP, and TTPH Shareholders About Its Ongoing Investigations
04/21/2020 GN NTGN, ETFC, TTPH, and MINI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
03/18/2020 GN Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of SB ONE, Tetraphase Pharmaceuticals, AVX, and Front Yard on behalf of Stockholders and Encourages Investors to Contact the Firm
03/17/2020 GN Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – WLTW, TTPH, ASRT, MEET
04/18/2019 GN New Research: Key Drivers of Growth for Quintana Energy Services, ProQR Therapeutics N.V, Tetraphase Pharmaceuticals, Biomerica, Heat Biologics, and Bellerophon Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
01/28/2019 GN Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Tetraphase Pharmaceuticals, Inc. (TTPH) and Encourages TTPH Investors to Contact the Firm
01/15/2019 GN New Research: Key Drivers of Growth for Tetraphase Pharmaceuticals, Olympic Steel, Belden, KAR Auction Services, BWX Technologies, and Sparton — Factors of Influence, Major Initiatives and Sustained Production
12/05/2018 GN Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference
11/29/2018 GN Report: Exploring Fundamental Drivers Behind Resonant, Constellation Brands, Masimo, Tetraphase Pharmaceuticals, LivaNova, and Penumbra — New Horizons, Emerging Trends, and Upcoming Developments
10/23/2018 GN Tetraphase Pharmaceuticals Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA™ (eravacycline) in Obese and Renally Impaired Patients with Complicated Intra-Abdominal Infections
10/08/2018 GN Tetraphase Pharmaceuticals Announces Presentation of Positive Data from Phase 3 Trials of XERAVA™ (eravacycline) and Multiple-Ascending Dose Trial of TP-6076 at IDWeek 2018
09/24/2018 GN Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.??(TTPH)
09/24/2018 GN Tetraphase Pharmaceuticals to Present at the Cantor Global Healthcare Conference
09/23/2018 GN CLASS ACTION UPDATE for RMTI, TTPH, HMNY and GDS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
09/21/2018 GN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZN, RMTI, TTPH, HMNY, PM and QRTEA
09/21/2018 GN DEADLINE ALERT- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tetraphase Pharmaceuticals, Inc. (TTPH) and Lead Plaintiff Deadline – September 25, 2018
09/20/2018 GN SHAREHOLDER ALERT: ZN RMTI TTPH ABBV HMNY GDS PVG OPK USAT TRCO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
09/20/2018 GN Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA™ (eravacycline) for the Treatment of Complicated Intra-Abdominal Infections
09/19/2018 GN Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) and TP-6076 Data at IDWeek 2018
09/18/2018 GN Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vuzix, Tetraphase, and LogMeIn and Encourages Investors to Contact the Firm
09/18/2018 GN CLASS ACTION UPDATE for SBGI, TTPH and HMNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
09/17/2018 GN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, FIZZ, RMTI, TTPH and FB
09/16/2018 GN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZN, RMTI, TTPH, HMNY and GDS
09/14/2018 GN Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Tetraphase Pharmaceuticals, Inc. Investors (TTPH)
09/14/2018 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tetraphase Pharmaceuticals, Inc. - TTPH
09/14/2018 GN SHAREHOLDER ALERT: PM QRTEA LOGM NLSN ACAD RMTI TTPH FB GDS SKX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
09/13/2018 GN CLASS ACTION UPDATE for PDD, SBGI and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
09/12/2018 GN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FIZZ, RMTI, TTPH, ABBV and GDS
09/09/2018 GN SHAREHOLDER ALERT: PDD AMPE NVRO PZZA ZN SBGI ACAD FIZZ TTPH FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy